Kyle M Fitzgerald

Publication Activity (10 Years)

Years Active: 2024-2024
Publications (10 Years): 6

Top Topics

Dendritic Cells

Epidermal Growth Factor Receptor

Infectious Diseases

Diffusion Weighted

Top Venues

Molecular cancer therapeutics

This page only lists publications with an associated author ORCID identifier.

Publications

Nimish Gera, Kyle M Fitzgerald, Vijay Ramesh, Purvi Patel, Deepak Kanojia, Federico Colombo, Lena Kien, Simon Aoyama, Lihui Xu, Jussekia Jean, Amit M Deshpande, William C Comb, Thomas Chittenden, Brian P Fiske
MYTX-011: a pH-dependent anti-cMET antibody-drug conjugate designed for enhanced payload delivery to cMET expressing tumor cells. Molecular cancer therapeutics (2024)
David L Niquille, Kyle M Fitzgerald, Nimish Gera
Biparatopic antibodies: therapeutic applications and prospects. mAbs 16 (1) (2024)
David L Niquille, Kyle M Fitzgerald, Nimish Gera
Biparatopic antibodies: therapeutic applications and prospects. mAbs 16 (1) (2024)
David L Niquille, Kyle M Fitzgerald, Nimish Gera
Biparatopic antibodies: therapeutic applications and prospects. mAbs 16 (1) (2024)
David L Niquille, Kyle M Fitzgerald, Nimish Gera
Biparatopic antibodies: therapeutic applications and prospects. mAbs 16 (1) (2024)
Nimish Gera, Kyle M Fitzgerald, Vijay Ramesh, Purvi Patel, Deepak Kanojia, Federico Colombo, Lena Kien, Simon Aoyama, Lihui Xu, Jussekia Jean, Amit M Deshpande, William C Comb, Thomas Chittenden, Brian P Fiske
MYTX-011: A pH-Dependent Anti-c-MET Antibody-Drug Conjugate Designed for Enhanced Payload Delivery to c-MET-Expressing Tumor Cells. Molecular cancer therapeutics (2024)